Molbio Diagnostics’ ₹940-crore IPO opened for subscription on August 10, 2026, following ₹281.5 crore raised from 33 anchor investors, including Goldman Sachs, BlackRock, HDFC Mutual Fund, and IFC. Notably, IFC’s participation marks the World Bank Group’s return to India’s mainboard IPO market after five years, reflecting continued institutional confidence in Molbio’s molecular diagnostics platform.